News

More than 2,000 rehabilitation professionals in a range of disciplines gathered in Toronto, Canada for the fourth biannual RehabWeek 2019. This combined event brought together seven professional organizations including the International Functional Electrical Stimulation Society, the American Congress of Rehabilitation Medicine, Rehabilitation Engineering and Assistive Technology Society of North Am…

Two recently published journal articles structural changes in neuromodulation approaches to stroke rehabilitation. The recommendations could hasten the commercialization of new stroke treatment devices. Neurotechnology-based therapies, including brain-machine interfaces, robotics, and brain stimulation, will lead to largest treatment effects and success if they are tailored to the needs of individu…

In the weeks following Elon Musk’s public launch of his brain interfacing company Neuralink [see article, page 1], numerous neurotechnology investigators and industry professionals have weighed in on the significance of the firm’s progress. Some, like Halo Neuroscience founder (and ex-NeuroPace executive) Dan Chao were highly impressed. “The Neuralink launch was one of the most impressive and visionary neuroscience presentations I have ever seen,” he tweeted.

In the last 10 years, the market for transcranial magnetic stimulation systems has shifted dramatically from applications primarily in neurosensing and neuroscience research to neuromodulation therapy for psychiatric disorders. A host of new competitors has entered the market in recent years and the range of indications treatable . At the recent meeting of the American Psychiatric Association in Sa…

About 1200 clinicians, neural engineers, and neuromodulation industry professionals attended the INS 14th World Congress in Sydney, Australia earlier this month. The meeting, produced , was the first one conducted in Australia. A preconference session called Innovations in Neuromodulation featured presentations -stage firms, three intermediate-stage firms, and five of the six major players in the spinal cord stimulation market (Nevro chose not to participate).

About 1200 clinicians, neural engineers, and neuromodulation industry professionals attended the INS 14th World Congress in Sydney, Australia earlier this month. The meeting, produced , was the first one conducted in Australia. A preconference session called Innovations in Neuromodulation featured presentations -stage firms, three intermediate-stage firms, and five of the six major players in the spinal cord stimulation market (Nevro chose not to participate).

The market for noninvasive brain stimulation has received considerable attention in recent months, as new vendors have entered the market and investigators have proposed new therapies. Earlier this month, the Swedish vendor Flow Neuroscience entered the U.K. market for depression with its £399 tDCS headset. In the U.S., Bay Area startup Humm announced plans to launch its consumer tACS headset that it says improves working memory.

Since it first arrived on the scene as a new form of neuromodulation, deep brain stimulation has been subject to its fair share of ethical scrutiny. As we have stated in this space in the past [NBR Jan17 p2, NBR Sep17 p2], it is important to recognize issues of privacy and informed consent whenever we are dealing with implanted brain devices The latest DBS ethics issue involves clinical trials of DBS for treating addiction, particularly trials conducted in China.

One of the most tantalizing challenges that has confronted neuroprosthetics researchers has been developing a speech prosthesis that can restore a user’s voice using a brain computer interface. Such a system would offer significant value to people who have lost vocal function as a result of ALS, stroke, TBI, or other neurological disorders. One early researcher, Philip Kennedy of Emory University,…

A newly published market research report from Neurotech Reports, the publisher of this newsletter, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025. The Market for Bioelectronic Medicine: 2020-2025 takes an in-depth look at the technology, markets, competitors, research, and growth rates in key applications areas in the years 2020 through 2025.